188 related articles for article (PubMed ID: 32884242)
21. Emodin palliates high-fat diet-induced nonalcoholic fatty liver disease in mice via activating the farnesoid X receptor pathway.
Shen C; Pan Z; Wu S; Zheng M; Zhong C; Xin X; Lan S; Zhu Z; Liu M; Wu H; Huang Q; Zhang J; Liu Z; Si Y; Tu H; Deng Z; Yu Y; Liu H; Zhong Y; Guo J; Cai J; Xian S
J Ethnopharmacol; 2021 Oct; 279():114340. PubMed ID: 34171397
[TBL] [Abstract][Full Text] [Related]
22. ASPP2 attenuates triglycerides to protect against hepatocyte injury by reducing autophagy in a cell and mouse model of non-alcoholic fatty liver disease.
Xie F; Jia L; Lin M; Shi Y; Yin J; Liu Y; Chen D; Meng Q
J Cell Mol Med; 2015 Jan; 19(1):155-64. PubMed ID: 25256142
[TBL] [Abstract][Full Text] [Related]
23. White Adipose Tissue Autophagy and Adipose-Liver Crosstalk Exacerbate Nonalcoholic Fatty Liver Disease in Mice.
Sakane S; Hikita H; Shirai K; Myojin Y; Sasaki Y; Kudo S; Fukumoto K; Mizutani N; Tahata Y; Makino Y; Yamada R; Kodama T; Sakamori R; Tatsumi T; Takehara T
Cell Mol Gastroenterol Hepatol; 2021; 12(5):1683-1699. PubMed ID: 34303881
[TBL] [Abstract][Full Text] [Related]
24. COX-2/sEH Dual Inhibitor Alleviates Hepatocyte Senescence in NAFLD Mice by Restoring Autophagy through Sirt1/PI3K/AKT/mTOR.
Zhang CY; Tan XH; Yang HH; Jin L; Hong JR; Zhou Y; Huang XT
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897843
[TBL] [Abstract][Full Text] [Related]
25. Coenzyme Q10 attenuates high-fat diet-induced non-alcoholic fatty liver disease through activation of the AMPK pathway.
Chen K; Chen X; Xue H; Zhang P; Fang W; Chen X; Ling W
Food Funct; 2019 Feb; 10(2):814-823. PubMed ID: 30675881
[TBL] [Abstract][Full Text] [Related]
26. Palmitic acid induces autophagy in hepatocytes via JNK2 activation.
Tu QQ; Zheng RY; Li J; Hu L; Chang YX; Li L; Li MH; Wang RY; Huang DD; Wu MC; Hu HP; Chen L; Wang HY
Acta Pharmacol Sin; 2014 Apr; 35(4):504-12. PubMed ID: 24608675
[TBL] [Abstract][Full Text] [Related]
27. Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice.
Tanaka S; Hikita H; Tatsumi T; Sakamori R; Nozaki Y; Sakane S; Shiode Y; Nakabori T; Saito Y; Hiramatsu N; Tabata K; Kawabata T; Hamasaki M; Eguchi H; Nagano H; Yoshimori T; Takehara T
Hepatology; 2016 Dec; 64(6):1994-2014. PubMed ID: 27637015
[TBL] [Abstract][Full Text] [Related]
28. Chicoric Acid Ameliorates Nonalcoholic Fatty Liver Disease via the AMPK/Nrf2/NF
Ding X; Jian T; Li J; Lv H; Tong B; Li J; Meng X; Ren B; Chen J
Oxid Med Cell Longev; 2020; 2020():9734560. PubMed ID: 33204402
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Notch1 signaling reduces hepatocyte injury in nonalcoholic fatty liver disease via autophagy.
Zhang M; Wu P; Li M; Guo Y; Tian T; Liao X; Tan S
Biochem Biophys Res Commun; 2021 Apr; 547():131-138. PubMed ID: 33610041
[TBL] [Abstract][Full Text] [Related]
30. Autophagy activation by Jiang Zhi Granule protects against metabolic stress-induced hepatocyte injury.
Zheng YY; Wang M; Shu XB; Zheng PY; Ji G
World J Gastroenterol; 2018 Mar; 24(9):992-1003. PubMed ID: 29531463
[TBL] [Abstract][Full Text] [Related]
31. C1q/TNF-Related Protein 9 (CTRP9) attenuates hepatic steatosis via the autophagy-mediated inhibition of endoplasmic reticulum stress.
Jung TW; Hong HC; Hwang HJ; Yoo HJ; Baik SH; Choi KM
Mol Cell Endocrinol; 2015 Dec; 417():131-40. PubMed ID: 26419929
[TBL] [Abstract][Full Text] [Related]
32. Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice.
Xia H; Zhu X; Zhang X; Jiang H; Li B; Wang Z; Li D; Jin Y
Biomed Pharmacother; 2019 Oct; 118():109287. PubMed ID: 31401392
[TBL] [Abstract][Full Text] [Related]
33. Icaritin ameliorates hepatic steatosis via promoting fatty acid β-oxidation and insulin sensitivity.
Xiong Y; Chen Y; Huang X; Yang Z; Zhang J; Yu X; Fang J; Tao J; You K; Cheng Z; Tan S; Xu Y; Yuan F; Liu Y; Zhuang Y; Yang F; Li Y
Life Sci; 2021 Mar; 268():119000. PubMed ID: 33417961
[TBL] [Abstract][Full Text] [Related]
34. Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.
Zhang J; Du H; Shen M; Zhao Z; Ye X
J Immunol Res; 2020; 2020():3413186. PubMed ID: 32884949
[TBL] [Abstract][Full Text] [Related]
35.
Park M; Yoo JH; Lee YS; Lee HJ
Nutrients; 2019 Feb; 11(3):. PubMed ID: 30813654
[TBL] [Abstract][Full Text] [Related]
36. Theaphenon E prevents fatty liver disease and increases CD4+ T cell survival in mice fed a high-fat diet.
Coia H; Ma N; Hou Y; Permaul E; Berry DL; Cruz MI; Pannkuk E; Girgis M; Zhu Z; Lee Y; Rodriquez O; Cheema A; Chung FL
Clin Nutr; 2021 Jan; 40(1):110-119. PubMed ID: 32439267
[TBL] [Abstract][Full Text] [Related]
37. SREBP-2/PNPLA8 axis improves non-alcoholic fatty liver disease through activation of autophagy.
Kim KY; Jang HJ; Yang YR; Park KI; Seo J; Shin IW; Jeon TI; Ahn SC; Suh PG; Osborne TF; Seo YK
Sci Rep; 2016 Oct; 6():35732. PubMed ID: 27767079
[TBL] [Abstract][Full Text] [Related]
38. Benzbromarone aggravates hepatic steatosis in obese individuals.
Sun P; Zhu JJ; Wang T; Huang Q; Zhou YR; Yu BW; Jiang HL; Wang HY
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2067-2077. PubMed ID: 29526820
[TBL] [Abstract][Full Text] [Related]
39. Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis.
Li J; Xie S; Teng W
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010950
[TBL] [Abstract][Full Text] [Related]
40. Maslinic acid protects against obesity-induced nonalcoholic fatty liver disease in mice through regulation of the Sirt1/AMPK signaling pathway.
Liou CJ; Dai YW; Wang CL; Fang LW; Huang WC
FASEB J; 2019 Nov; 33(11):11791-11803. PubMed ID: 31361524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]